ArticleFrontiers in immunology2024

TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells.

Beatrice Claudia Cianciotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.